Related Experiment Video
Updated: May 2, 2026

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Split G-Quadruplex-Integrated CRISPR-Cas Biosensor for One-Pot, Signal-On Visual Detection of Pathogen Nucleic Acids
Yan Zhang1, Yanan Lin1, Ruoxuan Li1
1School of Pharmacy, Nantong University, Nantong 226019, China.
A new G-quadruplex-integrated CRISPR-Cas biosensing platform enables rapid, one-pot colorimetric detection of pathogen nucleic acids. This novel system offers laboratory-comparable accuracy for disease surveillance and point-of-care diagnostics.
Area of Science:
- Molecular Biology
- Biotechnology
- Diagnostics
Background:
- Pathogen nucleic acid analysis is crucial for clinical management and disease surveillance.
- Existing methods can be time-consuming and require complex laboratory setups.
- There is a need for rapid, accurate, and accessible diagnostic tools for infectious diseases.
Purpose of the Study:
- To develop a novel, one-pot, colorimetric biosensing platform for pathogen nucleic acid detection.
- To integrate G-quadruplex structures with CRISPR-Cas systems for enhanced sensitivity and specificity.
- To create a user-friendly system suitable for point-of-care applications and real-time surveillance.
Main Methods:
- A G-quadruplex-integrated CRISPR-Cas biosensing platform utilizing a signal-on mechanism.
- Development of a universal visual probe for colorimetric detection coupled with Cas12 and Cas13 systems.
- Integration of recombinase polymerase amplification (RPA) with CRISPR-mediated cleavage in a tube-in-tube cartridge system.
- Validation using monkeypox virus (MPXV) and respiratory syncytial virus (RSV) as model targets.
Main Results:
- The platform demonstrated a distinct green colorimetric signal upon target recognition.
- Achieved a detection limit of 1 copy per test for MPXV and RSV.
- Showcased perfect concordance with PCR methods (40/40 agreement).
- Validated for detecting MPXV in environmental samples and RSV in clinical specimens.
Conclusions:
- The developed G-quadruplex-integrated CRISPR-Cas biosensing platform offers rapid (<60 min) and accurate pathogen detection.
- The one-pot, colorimetric system eliminates cross-contamination risks and simplifies workflow.
- This novel molecular diagnostic paradigm is suitable for real-time surveillance and point-of-care applications.
More Related Videos
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025